Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial

Implementation of complete mesogastric excision in gastric cancer surgery, named D2 lymphadenectomy plus complete mesogastric excision (D2+CME), has recently been proposed as an optimal procedure. However, the safety and efficacy of D2+CME remain uncertain. In this randomized controlled trial, patie...

Full description

Bibliographic Details
Main Authors: Xie, Daxing, Shen, Jie, Liu, Liang, Cao, Beibei, Wang, Yatao, Qin, Jichao, Wu, Jianhong, Yan, Qun, Hu, Yuanlong, Yang, Chuanyong, Cao, Zhixin, Hu, Junbo, Yin, Ping, Gong, Jianping
Format: Online Article Text
Language:English
Published: Elsevier 2021
Subjects:
Article
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974547/
https://www.ncbi.nlm.nih.gov/pubmed/33763656
http://dx.doi.org/10.1016/j.xcrm.2021.100217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974547/
https://www.ncbi.nlm.nih.gov/pubmed/33763656
http://dx.doi.org/10.1016/j.xcrm.2021.100217

Similar Items